5-ASAs in Crohn’s Disease: Time to Stop the Salicylate?-Reference-Cited by-同舟云学术

5-ASAs in Crohn’s Disease: Time to Stop the Salicylate?

Published:2021-11-19 Issue: Volume: Page:
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Honap Sailish,Sharma Esha,Samaan Mark A.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-021-07304-8.pdf

Reference9 articles.

1. Lim W-C, Wang Y, MacDonald JK, et al. Aminosalicylates for induction of remission or response in Crohn’s disease. Cochrane Database of Systematic Reviews [Internet]. 2016 [cited 2021 Sep 26];(7). Available from: https://www.cochranelibrary.com/cdsr/doi/https://doi.org/10.1002/14651858.CD008870.pub2/full

2. Akobeng AK, Zhang D, Gordon M, et al. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn’s disease. Cochrane Database Syst Rev. 2016 Sep 28;9:CD003715.

3. Hart A, Ng SC, Watkins J et al. The use of 5-aminosalicylates in Crohn’s disease: a retrospective study using the UK Clinical Practice Research Datalink. Ann Gastroenterol. 2020;33:500–507.

4. Ungaro RC, Limketkai BN, Jensen CB et al. Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes. Clin Gastroenterol Hepatol. 2020;18:1152-1160.e1.

5. Singh S, Kim J, Zhu W et al. No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy. Alimentary Pharmacology & Therapeutics. 2020;52:481–491.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α;The Korean Journal of Internal Medicine;2022-09-01